Skip to main content
OpenTrials
Completed

NCT Number: NCT01264666

Postprandial Effect of Chinese Tea Flavor Liquor on Selected CVD Risk Factors

Background: human studies of Chinese liquor are sparse. we hypothesis that Chinese Tea Flavor liquor may be beneficial to CVD risk factors postprandially.

Design: three-way crossover design with one week wash time.16 young men were included to consume 60mL Chinese tea flavor liquor(45% alcohol content), Chinese Meijiao liquor 45% alcohol content) or water control.Blood samples were collected fasted, 0.5,1,2,4 hours postprandially.

Tested serum indices: lipids, glucose, insulin, hs-CRP, uric acid, liver function parameters.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Alcohols Cardiovascular Diseases

Age range

20 year–30 year

Sex eligibility

Male

Study type

Interventional

Phase

Phase 1

Primary location

Department of Food Science of Nutrition, Zhejiang University

Hangzhou, Zhejiang, 310029, China

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • no CVD history or liver disease, healthy young men

Exclusion criteria

  • smokers

Treatment and study plan

Chinese tea flavor liquor

Dietary Supplement

60 mL of Chinese tea flavor liquor (45% alcohol content) is consumed with high-fat meal.

Chinese Meijiao liquor

Dietary Supplement

Water Control

Dietary Supplement

Primary outcomes

  1. serum sample

    Time frame: 4 hours

    blood samples were collected at 0,0.5,1,2,4 hours postprandially to get serum sample.

Interested in participating?

Completed

Looking for future studies?

Notify Me

Sponsors and collaborators

Lead sponsor

Zhejiang University

Other

Collaborators

  • Guizhou Meijiao Co., Ltd, China

Registry information

Official study title

Phase I Study of Chinese Tea Flavor Liquor on Human Health

Acronym: TFL

Important dates

Study start
2010
Primary completion
2010
Study completion
2010
First posted
Dec 22, 2010
Registry last updated
Dec 22, 2010

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.